Alibaba
BABA
Adobe
ADBE
Qualcomm
QCOM
4
Netflix
NFLX
5
Salesforce
CRM
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 558.520
- -45.060-7.47%
Close May 6 16:00 ET
- 571.500
- +12.980+2.32%
Post 18:23 ET
60.30BMarket Cap14.20P/E (TTM)
606.870High557.640Low1.42MVolume601.010Open603.580Pre Close809.82MTurnover1.37%Turnover Ratio14.57P/E (Static)107.97MShares1209.64552wk High2.05P/B58.06BFloat Cap525.99052wk Low0.88Dividend TTM103.95MShs Float1209.645Historical High0.16%Div YieldTTM8.16%Amplitude4.604Historical Low570.466Avg Price1Lot Size
Regeneron Pharmaceuticals Key Stats
EPS
According to the latest financial report of Regeneron Pharmaceuticals, the latest earnings per share (TTM) for the company is 7.27. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Regeneron Pharmaceuticals's free cash flow? The latest report shows it as 773.60M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Regeneron Pharmaceuticals shows that the company's current ratio is 4.93, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Regeneron Pharmaceuticals, the quick ratio is 3.90, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Regeneron Pharmaceuticals? The latest ROE figure is 2.75%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Regeneron Pharmaceuticals, the total asset return on investment (ROA) is 2.15%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Regeneron Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 84.67%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Regeneron Pharmaceuticals, the net profit margin is 26.70%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025